Stock Taper
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

TAO Synergies Inc. is a digital asset treasury company focused on acquiring, staking, and managing Bittensor (TAO) to provide investors exposure to the decentralized AI ecosystem and generate revenue through its TAO holdings.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
RLYB | $16.81 | COMPARE |
BOLD | $2.83 | COMPARE |
NXTC | $6.09 | COMPARE |
IBIO | $1.36 | COMPARE |
INTS | $4.25 | COMPARE |
CVKD | $1.54 | COMPARE |